Farid Ahmed
Papers
1
Total Citations
15
H-Index
1
About
Farid Ahmed is pioneering the intersection of bioprinting and cancer biology, with a focused expertise in creating advanced three-dimensional disease models of hematological malignancies. His major contribution lies in the development of an automated, robotic multicellular bioprinting system to fabricate a bone marrow niche-like model for acute myeloid leukemia (AML). This innovative approach directly addresses a critical bottleneck in oncology: the lack of physiologically relevant preclinical platforms that recapitulate the complex bone marrow microenvironment, which is central to understanding drug resistance and disease relapse. By engineering this controlled, reproducible 3D model, Ahmed provides researchers with a powerful tool to study AML biology and test novel therapies in a setting that more accurately mimics human disease. His work, exemplified by his highly cited 2023 paper, has garnered 15 citations in a short time, signaling its immediate impact on the field. Ahmed’s research is not merely technical; it is a translational bridge, offering a robust platform to identify resistance mechanisms and ultimately improve therapeutic outcomes for AML patients.
Research Focus
Key Achievements
Top Papers
- 1